These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8930574)

  • 1. Proton-pump inhibitors are the treatment of choice in acid-related disease.
    Brunner G
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S9-13. PubMed ID: 8930574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2001 Jul; 15(7):917-26. PubMed ID: 11421865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroduodenal Ulceration in Small Animals: Part 2. Proton Pump Inhibitors and Histamine-2 Receptor Antagonists.
    Daure E; Ross L; Webster CR
    J Am Anim Hosp Assoc; 2017; 53(1):11-23. PubMed ID: 27841679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication.
    Tan AC; Hartog GD; Mulder CJ
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.
    Lazzaroni M; Bianchi Porro G
    Drugs Aging; 1996 Oct; 9(4):251-61. PubMed ID: 8894523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.
    Martin RM; Lim AG; Kerry SM; Hilton SR
    Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
    Graham DY; Hammoud F; El-Zimaity HM; Kim JG; Osato MS; El-Serag HB
    Aliment Pharmacol Ther; 2003 May; 17(10):1229-36. PubMed ID: 12755836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
    Tanaka M; Banba M; Joko A; Moriyama Y
    Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
    Xue S; Katz PO; Banerjee P; Tutuian R; Castell DO
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1351-6. PubMed ID: 11552905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisecretory therapy for bleeding peptic ulcer.
    Peterson WL; Cook DJ
    JAMA; 1998 Sep; 280(10):877-8. PubMed ID: 9739959
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
    Zhou JF; Wan XY; Huang W; Han LL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease.
    Lambert R
    Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication-a meta-analysis.
    Holtmann G; Layer P; Goebell H
    Lancet; 1996 Mar; 347(9003):763. PubMed ID: 8602022
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M; Kato M; Sato Y; Miyazaki T
    Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.